|
HEATR6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.308000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.623400E-01 |
| Normal-vs-Stage2 |
2.418800E-01 |
| Normal-vs-Stage3 |
6.449200E-01 |
| Normal-vs-Stage4 |
5.267600E-01 |
| Stage1-vs-Stage2 |
4.993800E-01 |
| Stage1-vs-Stage3 |
6.015400E-01 |
| Stage1-vs-Stage4 |
8.405800E-01 |
| Stage2-vs-Stage3 |
3.456400E-01 |
| Stage2-vs-Stage4 |
4.921200E-01 |
| Stage3-vs-Stage4 |
8.242800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.406200E-01 |
| Normal-vs-AfricanAmerican |
8.860400E-03 |
| Normal-vs-Asian |
6.468100E-02 |
| Caucasian-vs-AfricanAmerican |
8.344900E-03 |
| Caucasian-vs-Asian |
1.087800E-01 |
| AfricanAmerican-vs-Asian |
2.164000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.991600E-01 |
| Normal-vs-Female |
2.810000E-01 |
| Male-vs-Female |
4.440200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.162600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.829600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.298200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.053000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.607200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.481200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.450360E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.622800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.873980E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.002400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.486000E-01 |
| Classical-VS-Follicular |
1.963870E-04 |
| Classical-VS-Other |
1.246750E-01 |
| Classical-VS-Normal |
5.160100E-02 |
| Tall-VS-Follicular |
1.783970E-01 |
| Tall-VS-Other |
3.163600E-01 |
| Tall-VS-Normal |
5.959400E-01 |
| Follicular-VS-Other |
7.823000E-01 |
| Follicular-VS-Normal |
3.787200E-01 |
| Other-VS-Normal |
5.099600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.063200E-01 |
| Normal-vs-N1 |
6.986400E-01 |
| N0-vs-N1 |
9.265000E-01 |
|
|
